Mercer Global Advisors
PAHC icon

Mercer Global Advisors’s Phibro Animal Health PAHC Stock Holding History

Mercer Global Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6K Buy
+1,610
New +$67.9K ﹤0.01% 4300

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mercer Global Advisors's PAHC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 1,610 shares worth $50.6K. The stake represents ﹤0.01% of the portfolio and ranks #4300 among its holdings.

195 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Mercer Global Advisors held 1,610 shares of Phibro Animal Health worth $50.6K as of Q2 2026.
  • Phibro Animal Health was a new Mercer Global Advisors position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4300 holding.
  • 195 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.